publication . Article . 2020

DO NSAIDS CAUSE SPECIFIC COMPLICATIONS IN COVID-19 CORONAVIRUS INFECTION?

A. E. Karateev; E. L. Nasonov; A. M. Lila;
Open Access
  • Published: 24 Jun 2020 Journal: Rheumatology Science and Practice, volume 58, pages 340-343 (issn: 1995-4484, eissn: 1995-4492, Copyright policy)
  • Publisher: Mediar Press
Abstract
<jats:p>Currently, there is no clear data indicating the risk of specific complications when using non-steroidal anti-inflammatory drugs (NSAIDs), and in particular ibuprofen, for COVID-19 infection. There is also no clear clinical evidence that taking NSAIDs increases the risk of COVID-19 infection. However, when using NSAIDs in patients with acute respiratory viral diseases, keep in mind the possibility of class-specific complications from the gastrointestinal tract, cardiovascular system and kidneys. This risk is quite serious in elderly patients with multiple comorbid diseases. In addition, you should remember that taking NSAIDs and paracetamol can mask impo...
Persistent Identifiers
Subjects
free text keywords: covid-19 infection, non-steroidal anti-inflammatory drugs, ibuprofen, paracetamol, acute respiratory viral diseases, complications, 2019-20 coronavirus outbreak, Medicine, business.industry, business, Clinical evidence, Respiratory system, Internal medicine, medicine.medical_specialty, In patient, Coronavirus disease 2019 (COVID-19), Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Gastrointestinal tract, Ibuprofen, medicine.drug, lcsh:Diseases of the musculoskeletal system, lcsh:RC925-935
Any information missing or wrong?Report an Issue